ResMed Announces Participation in the RBCCM Global Healthcare Conference
07. Mai 2024 16:05 ET
|
ResMed Inc.
SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Dr. Carlos Nunez, Chief Medical Officer, and Amy Wakeham, Chief Investor Relations Officer, will participate...
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024
25. April 2024 16:05 ET
|
ResMed Inc.
Year-over-year revenue grows 7%, operating profit up 25%, non-GAAP operating profit up 23%Operating cash flows of $402 million Note: A webcast of ResMed’s conference call will be available at...
ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024
04. April 2024 16:05 ET
|
ResMed Inc.
SAN DIEGO, April 04, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2024 on...
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
15. März 2024 03:05 ET
|
ResMed Inc.
ResMed announced the results of its 2024 Global Sleep Survey, uncovering a world in sleep crisis and encouraging people to discover their sleep superpowers
Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask
06. März 2024 09:05 ET
|
ResMed Inc.
ResMed unveils the AirFit F40, an ultra-compact full-face CPAP mask offering the comfort of smaller masks without sacrificing performance.
ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy Outcomes for Patients with Sleep Apnea
12. Februar 2024 16:16 ET
|
ResMed Inc.
ResMed launched AirCurve 11 bilevel devices to enhance sleep apnea device therapy options.
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024
24. Januar 2024 16:05 ET
|
ResMed Inc.
Year-over-year revenue grows 12%, operating profit down 2%, non-GAAP operating profit up 20%Resumed share repurchase program, repurchased $50 million during quarter Note: A webcast of ResMed’s...
ResMed to Report Second Quarter Fiscal 2024 Earnings on January 24, 2024
03. Januar 2024 16:05 ET
|
ResMed Inc.
SAN DIEGO, Jan. 03, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2024 on...
ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference
27. Dezember 2023 16:05 ET
|
ResMed Inc.
SAN DIEGO, Dec. 27, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer and chair of the board, will present at the 42nd Annual J.P. Morgan...
ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical Devices
20. Dezember 2023 16:05 ET
|
ResMed Inc.
SAN DIEGO, Dec. 20, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) is conducting a voluntary global field action to update its guides for all masks with magnets to inform users about...